RecruitingNCT06327594

Assessment System of Sarcopenia in Lung Cancer Patients

Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients


Sponsor

West China Hospital

Enrollment

1,500 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.


Eligibility

Min Age: 40 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study develops and tests a new assessment system for detecting sarcopenia (loss of muscle mass and strength) in patients with lung cancer who are having surgery. Sarcopenia is linked to worse surgical outcomes, and better tools to detect it early could help doctors optimize care before and after surgery. **You may be eligible if...** - You are a hospital inpatient scheduled for curative surgery for lung cancer - You have had a CT or MRI scan within the past week - You are willing and able to comply with all assessments **You may NOT be eligible if...** - You have had an arm or leg amputated - You have severe swelling (edema) above the knee level - You have an implantable pacemaker - You have impaired consciousness or poor health that prevents you from completing the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTultrasound scan

The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by ultrasound at multiple sites of the whole body, including muscle and fat.

DIAGNOSTIC_TESTCT/MRI scan

The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by abdominal CT/MRI.


Locations(1)

Xinyi Tang

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06327594


Related Trials